- Missouri voters oppose prescription-only restrictions on PSE
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Senate passes Drug Quality and Security Act
MISSION, Kan. — ScriptPro's Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.
ScriptPro said its system now interfaces with the Appriss National Precursor Log Exchange system, currently used by pharmacies and law enforcement agencies in 22 states to track products like pseudoephedrine-based cold and allergy remedies. ScriptPro said the interface eliminates the need to keep a manual log to document sales of the products.
NPLEx works by tracking product requirements, alerting for entry of required patient identification data, sending back approval or denial and blocking any transaction that would cause the customer to exceed legal limits. The National Association of Drug Diversion Investigators makes NPLEx available for free to states that require monitoring of precursor purchases and agree to use the system.
"ScriptPro is pleased to partner with Appriss to offer this time-saving, and in some cases life-saving tool to pharmacies operating in states that have adopted NPLEx," ScriptPro president and CEO Mike Coughlin said. "It reduces manual record keeping and saves operating costs for these pharmacies while at the same time providing better protection for the public."